Is Response to Prophylactic Lithium a Familial Trait?
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Selecting a drug according to the treatment response in a relative has been widely accepted advice in the management of mood disorders. However, this recommendation has not been adequately substantiated in the literature. We tested the hypothesis that response to long-term lithium treatment is a familial trait. METHOD: We compared response to long-term lithium treatment in bipolar relatives of bipolar lithium responders and bipolar controls. Twenty-four relatives with bipolar disorder (as determined using the Schedule for Affective Disorders and Schizophrenia-Lifetime version [SADS-L] and Research Diagnostic Criteria [RDC]) were identified in families of 106 patients with lithium-responsive bipolar disorder. A consecutive series of 40 lithium-treated patients in a bipolar clinic (meeting RDC and DSM-IV criteria for bipolar disorder) served as a comparison group. Lithium response was evaluated on a rating scale reflecting the quality and quantity of available data. RESULTS: The prevalence of unequivocal response among the relatives was 67%, as compared with the response rate of 35% in the comparison group (chi2 = 6.04, df = 1, p = .014). CONCLUSION: This highly significant difference in response between relatives and the control group supports the view that the response to lithium prophylaxis clusters in families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“with a study showing that patients who have a lithium‐responsive relative have a 67% likelihood of also being lithium responsive, versus 35% of those without a responsive relative.417”
Citations
Cites
Research Diagnostic Criteria: Rationale and Reliability
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,951
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
Kaplan and Sadock's synopsis of psychiatry
Sadock, B. J., & Sadock, V. A. (1998) · Cited by 450
Relationship Between the Effectiveness of Lithium Therapy and Family History
MENDLEWICZ, J., FIEVE, R. R., & STALLONE, F. (1973) · American Journal of Psychiatry · doi:10.1176/ajp.130.9.1011 · Cited by 166
DIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTS
Pare, C. M. B., Rees, L., & Sainsbury, M. J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91019-x · Cited by 165
Does Lithium Treatment Still Work?: Evidence of Stable Responses Over Three Decades
Baldessarini, R. J., & Tondo, L. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.2.187 · Cited by 164
Lithium response and genetics of affective disorders
Grof, P., Alda, M., Gror, E., Zvolsky, P., & Walsh, M. (1994) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)90066-3 · Cited by 161
Self-citationFamilial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
Franchini, L., Serretti, A., Gasperini, M., & Smeraldi, E. (1998) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)00004-1 · Cited by 156
Evidence for a role of phospholipase C-γ1 in the pathogenesis of bipolar disorder
Turecki, G., Grof, P., Cavazzoni, P. A., Duffy, A. C., Grof, E., Ahrens, B., Berghöfer, A., Müller-Oerlinghausen, B., Dvorakova, M. C., Libigerová, E., et al. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000447 · Cited by 127
Self-citationPharmacogenetic response to antidepressants in a multicase family with affective disorder
O’Reilly, R. L., Bogue, L., & Singh, S. M. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90642-4 · Cited by 116
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Self-citationMetallodrugs in Medicinal Inorganic Chemistry
Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,289
Family, twin, and adoption studies of bipolar disorder
Smoller, J. W., & Finn, C. T. (2003) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.20013 · Cited by 714
“[1994, 1997] have observed familial clustering of lithium responsiveness and report segregation analyses consistent with single major gene transmission [Grof et al., 2002].”
ResultGrunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & on behalf of the WFSBP Task Force on Treatment Guidelines for Bipolar Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.770551 · Cited by 421
“_____________________ Insert Table 1 about here _____________________ Less formalistic, but probably more informative is an approach introduced by Grof et al (Grof et al 2002), the so called Alda scale.”
BackgroundManchia, M., Adli, M., Akula, N., Ardau, R., Aubry, J.-M., Backlund, L., Banzato, C. E., Baune, B. T., Bellivier, F., Bengesser, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065636 · Cited by 417
“These results confirmed that TS $7 is the most appropriate cut off for the definition of full response to lithium prophylaxis as suggested in previous studies [12,13].”
InfluentialSelf-citationThe genetics of bipolar disorder
Barnett, J. H., & Smoller, J. W. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.03.080 · Cited by 407
“, 2007) and lithium-responsiveness(Grof et al., 2002), suicidality (Saunders et al.”
Hou, L., Heilbronner, U., Degenhardt, F., Adli, M., Akiyama, K., Akula, N., Ardau, R., Arias, B., Backlund, L., Banzato, C. E. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00143-4 · Cited by 385
Self-citationCandidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
Alda, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.4 · Cited by 315
Self-citationDuffy, A., Alda, M., Crawford, L., Milin, R., & Grof, P. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00421.x · Cited by 233
Self-citationProphylactic treatment response in bipolar disorder: Results of a naturalistic observation study
Garnham, J., Munro, A., Slaney, C., MacDougall, M., Passmore, M., Duffy, A., O'Donovan, C., Teehan, A., & Alda, M. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.03.003 · Cited by 205
“As in our previous study, full responders were defined as patients who had a total score of 7 or higher; these patients were considered in remission as defined by standard criteria such as CGI for all or most of the treatment time (Grof et al., 2002).”
MethodSelf-citationGrandjean, E. M., & Aubry, J.-M. (2009) · CNS Drugs · doi:10.2165/00023210-200923040-00005 · Cited by 203
Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres
Martinsson, L., Wei, Y., Xu, D., Melas, P. A., Mathé, A. A., Schalling, M., Lavebratt, C., & Backlund, L. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.37 · Cited by 179
“Lithium response (LiR) clusters in families to a large extent, but it is difficult to identify these responders a priori among patients because of the lack of predictive biomarkers.(7) Lithium is thought to stabilize neuronal activities and to promote neural plasticity and neuroprotection.”
BackgroundMethodInfluentialTreatment of bipolar disorder: a systematic review of available data and clinical perspectives
Fountoulakis, K. N., & Vieta, E. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009231 · Cited by 169
“Patients with an episodic course with euthymic intervals, and the absence of rapid cycling may respond better to lithium (Bowden et al., 2000b; Faedda et al., 1991; Grof, 2003; Grof et al., 1994, 2002).”
BackgroundStern, S., Santos, R., Marchetto, M. C., Mendes, A. P. D., Rouleau, G. A., Biesmans, S., Wang, Q.-W., Yao, J., Charnay, P., Bang, A. G., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2016.260 · Cited by 169
Self-citationPerlis, R. H., Smoller, J. W., Ferreira, M. A. R., McQuillin, A., Bass, N., Lawrence, J., Sachs, G. S., Nimgaonkar, V., Scolnick, E. M., Gurling, H., et al. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.08111633 · Cited by 164
“As a result, we were unable to utilize the criteria for good versus poor lithium response, as developed by Grof and colleagues (11), which relies on knowledge of prelithium course.”
Schulze, T. G., Alda, M., Adli, M., Akula, N., Ardau, R., Bui, E. T., Chillotti, C., Cichon, S., Czerski, P., Del Zompo, M., et al. (2010) · Neuropsychobiology · doi:10.1159/000314708 · Cited by 163
Self-citationDuffy, A., Goodday, S., Keown-Stoneman, C., & Grof, P. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040461 · Cited by 158
Self-citationInsulin resistance and outcome in bipolar disorder
Calkin, C. V., Ruzickova, M., Uher, R., Hajek, T., Slaney, C. M., Garnham, J. S., O'Donovan, M. C., & Alda, M. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.152850 · Cited by 158
Self-citationVariant GADL1 and Response to Lithium Therapy in Bipolar I Disorder
Chen, C.-H., Lee, C.-S., Lee, M.-T. M., Ouyang, W.-C., Chen, C.-C., Chong, M.-Y., Wu, J.-Y., Tan, H. K.-L., Lee, Y.-C., Chuo, L.-J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1212444 · Cited by 156
Bipolar disorder and mechanisms of action of mood stabilizers
Rapoport, S. I., Basselin, M., Kim, H.-W., & Rao, J. S. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.06.003 · Cited by 155
“Familial factors can determine responsiveness to lithium, the drug of choice for the disease (Alda, 1999; Grof et al., 2002).”
Vieta, E., & Phillips, M. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm057 · Cited by 146
“There may be a familial disposition to lithium response.(26) Bipolar patients are also more likely to switch to mania when treated with antidepressants than unipolar patients.”
BackgroundInternational Consortium on Lithium Genetics (ConLi+Gen), Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Heilbronner, U., Degenhardt, F., Tekola-Ayele, F., Hsu, Y.-H., et al. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.3433 · Cited by 143
Self-citationA systematic review and meta‐analysis of clinical predictors of lithium response in bipolar disorder
Hui, T. P., Kandola, A., Shen, L., Lewis, G., Osborn, D. P. J., Geddes, J. R., & Hayes, J. F. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13062 · Cited by 138
“(including sample size and number of lithium responders and non-responders; (ii) intervention details (dose, duration of lithium treatment); (iii) definition of a treatment response (number of recurrence under lithium treatment, reduction in time spent in hospital under lithium treatment, reduction of episode frequenc…”
BackgroundTherapeutic Mechanisms of Lithium in Bipolar Disorder: Recent Advances and Current Understanding
Malhi, G. S., & Outhred, T. (2016) · CNS Drugs · doi:10.1007/s40263-016-0380-1 · Cited by 146
“Since the demonstration that excellent lithium response may be inherited [132], researchers have been examining pharmacogenetic models of lithium response.”
BackgroundEfficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry
Fountoulakis, K. Ν., Kasper, S. F., Andreassen, O. A., Blier, P., Okasha, A., Severus, E., Versiani, M., Tandon, R., Möller, H., & Vieta, E. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-012-0323-x · Cited by 149
“course with euthymic intervals and the absence of rapid cycling may respond better to lithium [76, 160, 230–232].”
BackgroundAmare, A. T., Schubert, K. O., & Baune, B. T. (2017) · EPMA Journal · doi:10.1007/s13167-017-0112-8 · Cited by 129
“While clinical studies report a combination of demographic and clinical characteristics as potential predictors of treatment response in mood disorder patients [66], genetic factors are also highly involved in lithium treatment response with a potential interplay between genetic and environmental factors [47, 56].”
BackgroundMolecular actions and clinical pharmacogenetics of lithium therapy
Can, A., Schulze, T. G., & Gould, T. D. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.004 · Cited by 120
“The accumulating evidence indicates that lithium-responsive bipolar disorder patients have a greater likelihood of having relatives with bipolar disorder (Mendlewicz et al., 1973), and a greater chance of having other lithium-responsive relatives (Grof et al., 2002).”
BackgroundMethodInfluentialMcCarthy, M. J., Wei, H., Nievergelt, C. M., Stautland, A., Maihofer, A. X., Welsh, D. K., Shilling, P., Alda, M., Alliey-Rodriguez, N., Anand, A., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0273-8 · Cited by 115
Self-citationPhenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine
Passmore, M. J., Garnham, J., Duffy, A., MacDougall, M., Munro, A., Slaney, C., Teehan, A., & Alda, M. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00026.x · Cited by 109
Self-citation(ICCBD), M. O. T. I. C. C. F. B. D., Song, J., Bergen, S. E., Florio, A. D., Karlsson, R., Charney, A. W., Ruderfer, D. M., Stahl, E. A., Chambert, K. D., Moran, J. L., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.165 · Cited by 111
Challenges and Future Prospects of Precision Medicine in Psychiatry
Manchia, M., Pisanu, C., Squassina, A., & Carpiniello, B. (2020) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s198225 · Cited by 134
The phenotypes of bipolar disorder: relevance for genetic investigations
MacQUEEN, G. M., Hájek, T., & Alda, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001701 · Cited by 108
Self-citationMcCarthy, M. J., Nievergelt, C. M., Shekhtman, T., Kripke, D. F., Welsh, D. K., & Kelsoe, J. R. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2011.00725.x · Cited by 97
“The majority of subjects were also scored on the 10 point Alda scale of Li response (Grof et al. 2002).”
BackgroundDuffy, A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500802 · Cited by 92
“to treatment) into the selection of the mood stabilizer for that patient improves their outcome dramatically, compared with outcomes from randomly chosen treatments listed in generic treatment guidelines.(35,36,53)”
Self-citationSquassina, A., Manchia, M., Borg, J., Congiu, D., Costa, M. F., Georgitsi, M., Chillotti, C., Ardau, R., Mitropoulos, K. A., Severino, G., et al. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.102 · Cited by 103
Amare, A. T., Schubert, K. O., Hou, L., Clark, S. R., Papiol, S., Cearns, M., Heilbronner, U., Degenhardt, F., Ayele, F. T., Hsu, Y., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0689-5 · Cited by 102
“Inter-episode residual mood symptoms, as opposed to full remission [6, 7, 33], a rapid cycling pattern [32, 33], and a history of mixed episodes [34, 35] have also been described as predictors of poor response.”
Self-citationSixty Years of Lithium Responders
Grof, P. (2010) · Neuropsychobiology · doi:10.1159/000314305 · Cited by 95
Self-citationToward a Comprehensive Clinical Staging Model for Bipolar Disorder: Integrating the Evidence
Duffy, A. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405901208 · Cited by 90
Self-citationDuffy, A., Alda, M., Milin, R., & Grof, P. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200606 · Cited by 90
“previous findings that lithium response clusters in affected adult family members.(45)”
BackgroundSelf-citationA longitudinal approach to biological psychiatric research: The PsyCourse study
Budde, M., Anderson‐Schmidt, H., Gade, K., Reich‐Erkelenz, D., Adorjan, K., Kalman, J. L., Senner, F., Papiol, S., Andlauer, T. F. M., Comes, A. L., et al. (2018) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32639 · Cited by 94
“In addition, a comprehensive set of phenotype data is collected, assessing symptom dimensions, cognitive function, and self-report measures (Supporting Information Table 1; Altman, Hedeker, Peterson, & Davis, 1997; American Psychiatric Association, 2002; Angermeyer, Kilian, & Matschinger, 2000; Army Individual Test Ba…”
Pharmacogenetics and outcome with antipsychotic drugs
Pouget, J. G., Shams, T. A., Tiwari, A. K., & Müller, D. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/jpouget · Cited by 108
Prediction of lithium response using clinical data
Nunes, A., Ardau, R., Berghöfer, A., Bocchetta, A., Chillotti, C., Deiana, V., Garnham, J. S., Grof, E., Hájek, T., Manchia, M., et al. (2019) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13122 · Cited by 95
“Other features of the classical phenotype, such as family history (10, 24), did not arise as important predictors.”
BackgroundSelf-citationResponse to Lithium in Bipolar Disorder: Clinical and Genetic Findings
RYBAKOWSKI, J. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000277 · Cited by 99
Schulze, T. G. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.10.005 · Cited by 91
Squassina, A., Costa, M., Congiu, D., Manchia, M., Angius, A., Deiana, V., Ardau, R., Chillotti, C., Severino, G., Calza, S., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.04.004 · Cited by 80
Andreazza, A. C., & Young, L. T. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000096 · Cited by 80
“These findings also reported that the majority of relatives, of lithium responders, also benefitted from long-term administration of lithium (Grof et al., 2002).”
BackgroundPharmacogenetics of Lithium Response in Bipolar Disorder
McCarthy, M. J., Leckband, S. G., & Kelsoe, J. R. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.127 · Cited by 79
Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder: Current Status of Knowledge
RYBAKOWSKI, J. K. (2013) · CNS Drugs · doi:10.1007/s40263-013-0040-7 · Cited by 95
“) introduced a scale allowing quantitative retrospective assessment of the quality of prophylactic lithium response [27].”
BackgroundBrain age in bipolar disorders: Effects of lithium treatment
Gestel, H. V., Franke, K., Petite, J., Slaney, C., Garnham, J. S., Helmick, C. A., Johnson, K., Uher, R., Alda, M., & Hájek, T. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419857814 · Cited by 83
“, 2000) to obtain a detailed description of clinical course and Alda Scale to assess prophylactic response to Li (Grof et al., 2002; Manchia et al., 2013).”
MethodSelf-citationPolymorphism of circadian clock genes and prophylactic lithium response
RYBAKOWSKI, J. K., Dmitrzak‐Węglarz, M., Kliwicki, S., & Hauser, J. (2013) · Bipolar Disorders · doi:10.1111/bdi.12136 · Cited by 82
“Eleven years ago, Canadian researchers (Martin Alda and colleagues) introduced a scale allowing the quantitative retrospective assessment of the prophylactic lithium response (19).”
BackgroundMethodAlda, M., Grof, P., Rouleau, G. A., Turecki, G., & Young, L. T. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.021 · Cited by 85
Self-citationOedegaard, K. J., Alda, M., Anand, A., Andreassen, O. A., Balaraman, Y., Berrettini, W. H., Bhattacharjee, A. K., Brennand, K., Burdick, K. E., Calabrese, J. R., et al. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0732-x · Cited by 74
“have shown that affected relatives of lithium-responsive bipolar probands are more likely to also be lithium responsive than the relatives of nonlithium-responsive probands [36].”
BackgroundSelf-citationLithium response across generations
Grof, P., Duffy, A. C., Alda, M., & Hájek, T. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01454.x · Cited by 75
“There are good reasons for optimism: Both BD and lithium response cluster in families (46), the illness itself appears to have the strongest genetic Grof et al.”
BackgroundSelf-citationTEMPS-A and long-term lithium response: Positive correlation with hyperthymic temperament
RYBAKOWSKI, J. K., Dembińska-Krajewska, D., Kliwicki, S., Akiskal, K. K., & Akiskal, H. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.07.028 · Cited by 75
“Ten years ago, Canadian researchers (Martin Alda and colleagues) introduced a scale allowing quantitatively retrospectively assess the quality of prophylactic lithium response (Grof et al., 2002).”
BackgroundFrye, M. A., McElroy, S. L., Fuentes, M. E., Sutor, B., Schak, K. M., Galardy, C. W., Palmer, B. A., Prieto, M. L., Kung, S., Sola, C. L., et al. (2015) · International Journal of Bipolar Disorders · doi:10.1186/s40345-015-0030-4 · Cited by 80
“…is The Consortium for Lithium Genetics, the goal of which is to facilitate high-quality, well-powered genomic analyses of lithium treatment response (Schulze et al. 2010) with a narrow standardized phenotype of prophylactic lithium response quantified using the Alda Scale (Grof et al. 2002).”
MethodAntidepressant-like responses to lithium in genetically diverse mouse strains
Can, A., Blackwell, R. A., Piantadosi, S. C., Dao, D. T., O’Donnell, K. C., & Gould, T. D. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00682.x · Cited by 77
“1973), and those relatives in turn are more likely to respond favorably to lithium therapy (Grof et al. 2002).”
BackgroundPrediction of treatment outcomes in psychiatry—where do we stand ?
McMahon, F. J. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.4/fmcmahon · Cited by 83
Squassina, A., Pisanu, C., Congiu, D., Caria, P., Frau, D. V., Niola, P., Melis, C., Baggiani, G., López, J. P., Cruceanu, C., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.03.020 · Cited by 82
“Patients were characterized for lithium response using the “Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder” as described previously (Grof et al., 2002; Manchia et al., 2013).”
MethodPredictors of lithium response in bipolar disorder
Tighe, S. K., Mahon, P. B., & Potash, J. B. (2011) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311399173 · Cited by 78
“The prevalence of unequivocal response among the relatives was 67%, as compared with a response rate of 35% in the comparison clinic group [Grof et al. 2002].”
ResultPharmacogenomics: A road ahead for precision medicine in psychiatry
Pardiñas, A. F., Owen, M. J., & Walters, J. (2021) · Neuron · doi:10.1016/j.neuron.2021.09.011 · Cited by 90
Lithium response in bipolar disorders and core clock genes expression
Geoffroy, P. A., Curis, E., Courtin, C., Moreira, J., Morvillers, T., Étain, B., Laplanche, J., Bellivier, F., & Marie-Claire, C. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1282174 · Cited by 75
“For all patients, the response to Li was rated using the Alda scale (Grof et al. 2002) by two trained psychiatrists (PAG and BE), who participated in a study on the reliability of the scale (Manchia et al. 2013).”
MethodCurrent psychotropic medication prescribing patterns in late‐life bipolar disorder
Rej, S., Herrmann, N., Shulman, K., Fischer, H. D., Fung, K., & Gruneir, A. (2017) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4635 · Cited by 69
“Despite rates of lithium-response that are also 30–50% (Chen et al., 2014; Grof et al., 2002), one may expect North American lithium prescribing in late-life bipolar disorder to be much lower than this.”
BackgroundResultInfluentialSantos, R., Linker, S. B., Stern, S., Mendes, A. P. D., Shokhirev, M. N., Erikson, G. A., Randolph‐Moore, L., Racha, V., Kim, Y., Kelsoe, J. R., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00981-3 · Cited by 75
Self-citationDuffy, A. C., Horrocks, J., Milin, R., Doucette, S., Persson, G., & Grof, P. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.010 · Cited by 82
Self-citationFamily-Based Association Study of Lithium-Related and Other Candidate Genes in Bipolar Disorder
Perlis, R. H., Purcell, S., Fagerness, J., Kirby, A., Petryshen, T. L., Fan, J., & Sklar, P. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.15 · Cited by 67
Clinical factors associated with lithium response in bipolar disorders
Sportiche, S., Geoffroy, P. A., Brichant‐Petitjean, C., Gard, S., Khan, J.-P., Azorin, J., Henry, C., Leboyer, M., Étain, B., Scott, J. L., et al. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416664794 · Cited by 72
“…treated with lithium are classified as excellent responders (e.g. demonstrating a total absence of affective episodes over a 10-year period of lithium prophylaxis), while Grof et al. (2002) noted that the response rate may be increased further in first-degree relatives of lithium responders.”
BackgroundMethodInfluentialPrediction of response to drug therapy in psychiatric disorders
Stern, S., Linker, S. B., Vadodaria, K. C., Marchetto, M. C., & Gage, F. H. (2018) · Open Biology · doi:10.1098/rsob.180031 · Cited by 68
Malhi, G. S., Gershon, S., & Outhred, T. (2016) · Bipolar Disorders · doi:10.1111/bdi.12455 · Cited by 65
Lithium for bipolar disorder: a review of the recent literature
Curran, G., & Ravindran, A. V. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.947965 · Cited by 67
“Other predictors of a favorable response to lithium recognized elsewhere in the literature include long depression-free intervals, absence of rapid cycling or comorbid substance and alcohol issues [116], a family history of lithium responders [117] and low comorbidities [10].”
BackgroundEtain, B., Lajnef, M., Brichant‐Petitjean, C., Geoffroy, P. A., Henry, C., Gard, S., Kahn, J. P., Leboyer, M., Young, A. H., & Bellivier, F. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12684 · Cited by 62
“having a Montgomery Asberg Depression Rating Scale score (33) and a Mania Rating Scale score (34) below five, as well as no major mood episodes in the last 3 months); having completed the Childhood Trauma Questionnaire (35); and whose response to lithium has been assessed using the ‘Alda scale’ (2).”
BackgroundMethodSchubert, K. O., Thalamuthu, A., Amare, A. T., Frank, J., Streit, F., Adl, M., Akula, N., Akiyama, K., Ardau, R., Arias, B., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01702-2 · Cited by 62
“absence of physical co-morbidity [19, 20]; manic index episode [19]; family history of favourable lithium treatment [21] are associated with better treatment response, but none of these variables are sufficient to guide lithium prescribing on an individual basis.”
BackgroundSelf-citationNew Advances in the Pharmacology and Toxicology of Lithium: A Neurobiologically Oriented Overview
Bortolozzi, A. A., Fico, G., Berk, M., Solmi, M., Fornaro, M., Quevedo, J., Zarate, C. A., Kessing, L. V., Vieta, E., & Carvalho, A. F. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000007 · Cited by 73
Geoffroy, P. A., Étain, B., Lajnef, M., Zerdazi, E., Brichant‐Petitjean, C., Heilbronner, U., Hou, L., Degenhardt, F. C., Rietschel, M., McMahon, F. J., et al. (2016) · Genes Brain & Behavior · doi:10.1111/gbb.12306 · Cited by 67
“For all patients, the Li response was rated using the ‘Retrospective Criteria of Long-Term Treatment Response in Research Subjects with Bipolar Disorder’, also referred to as the Alda scale (Grof et al. 2002).”
MethodPost, R. M., Ketter, T. A., Uhde, T. W., & Ballenger, J. C. (2007) · CNS Drugs · doi:10.2165/00023210-200721010-00005 · Cited by 71
Serretti, A., Malitas, P. N., Mandelli, L., Lorenzi, C., Ploia, C., Alevizos, B., Nikolaou, C., Boufidou, F., Christodoulou, G. N., & Smeraldi, E. (2004) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500252 · Cited by 65
Cellular models to study bipolar disorder: A systematic review
Viswanath, B., Jose, S. P., Squassina, A., Thirthalli, J., Purushottam, M., Mukherjee, O., Vladimirov, V. I., Patrinos, G. P., Zompo, M. D., & Jain, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.05.037 · Cited by 74
“Considering that BD is a disorder with high heritability and that even Lithium response in BD is familial (Grof et al., 2002), there is a need for studies to focus on the heritability of biological processes itself in BD.”
BackgroundKim, B., Kim, C. Y., Lee, M., & Joo, Y. H. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.05.010 · Cited by 62
“Full responders were defined as patients who had a total score of at least 7 and who were reported to correspond to remission as defined by standard criteria such as the Clinical Global Impression (CGI) (Grof et al., 2002).”
BackgroundMethodInfluentialEvidence for an association between tumor necrosis factor-alpha levels and lithium response
Gülöksüz, S., Altınbaş, K., Çetin, E. A., Kenis, G., Gazioglu, S. B., Deniz, G., Oral, E., & van Os, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.04.044 · Cited by 59
“The ALDA lithium response scale (LRS) was used to evaluate longitudinal lithium response in bipolar patients retrospectively (Grof et al., 2002).”
MethodDoes Bipolar Disorder Exist in Children? A Selected Review
Duffy, A. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705200702 · Cited by 56
Self-citationRYBAKOWSKI, J. K., Permoda‐Osip, A., & Borkowska, A. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.06.002 · Cited by 59
“The offspring of patients with a different effect of lithium may show clinical and neuropsychological similarities to their parents (Grof et al., 2002).”
BackgroundLithium therapy and its interactions
Malhi, G. S., Bell, E., Outhred, T., & Berk, M. (2020) · Australian Prescriber · doi:10.18773/austprescr.2020.024 · Cited by 58
Implication of synapse-related genes in bipolar disorder by linkage and gene expression analyses
de Lara, C. L., Jaitovich-Groisman, I., Cruceanu, C., Mamdani, F., Lebel, V., Yerko, V., Beck, A., Young, L. T., Rouleau, G., Grof, P., et al. (2010) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000714 · Cited by 55
Self-citationSalivary cortisol secretion in remitted bipolar patients and offspring of bipolar parents
Deshauer, D., Duffy, A., Meaney, M., Sharma, S., & Grof, P. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00338.x · Cited by 53
Self-citationAssociation of BDNF Gene Polymorphism with Bipolar Disorders in Han Chinese Population
Wang, Z., Li, Z., Chen, J., Huang, J., Yuan, C., Hong, W., Yu, S., & Fang, Y. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00797.x · Cited by 53
“All patients who had been treated first with lithium or valproate were reviewed by one trained research assistant using a scale described previously (Grof et al. 2002).”
MethodEpigenetics in bipolar disorder: a critical review of the literature
Legrand, A., Iftimovici, A., Khayachi, A., & Chaumette, B. (2021) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000267 · Cited by 48
“The trait of being an excellent responder to lithium salts segregated in families (Grof et al., 2002), while the lifetime risk of developing the disease for first-degree relatives of bipolar probands was 8,7% (Smoller and Finn, 2003).”
BackgroundMarie-Claire, C., Lejeune, F., Mundwiller, E., Ulveling, D., Moszer, I., Bellivier, F., & Étain, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-69073-0 · Cited by 57
Scott, J. L., Étain, B., Manchia, M., Brichant‐Petitjean, C., Geoffroy, P. A., Schulze, T. G., Alda, M., Bellivier, F., & collaborators, C. (2019) · Bipolar Disorders · doi:10.1111/bdi.12829 · Cited by 61
Self-citationSelecting effective long-term treatment for bipolar patients: monotherapy and combinations.
Grof, P. (2003) · PubMed · Cited by 57
Self-citationGenetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees
Manchia, M., Hajek, T., O'Donovan, C., Deiana, V., Chillotti, C., Ruzickova, M., Del Zompo, M., & Alda, M. (2013) · Bipolar Disorders · doi:10.1111/bdi.12088 · Cited by 48
“Specifically, we evaluated the effectiveness of lithium prophylaxis using a previously validated scale that expresses the clinical improvement (weighted by confounding factors) with a total score (TS) ranging from 0 to 10 (36, 37).”
MethodSelf-citationThe Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine
Pisanu, C., Heilbronner, U., & Squassina, A. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0335-y · Cited by 51
Stargazin involvement with bipolar disorder and response to lithium treatment
Silberberg, G., Levit, A., Collier, D., St. Clair, D., Munro, J., Kerwin, R. W., Tondo, L., Floris, G., Breen, G., & Navon, R. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f974ca · Cited by 48
Do the Trajectories of Bipolar Disorder and Schizophrenia Follow a Universal Staging Model?
Duffy, A., Malhi, G. S., & Grof, P. (2017) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716649189 · Cited by 46
“The concept of kindling has proven difficult to substantiate and is incompatible with observations on the lithium-responsive BD subtype as its course does not exhibit a progressive worsening nor a shortening of the interepisode interval predicted by kindling theory.13,22 For example, according to the kindling model, i…”
ResultInfluentialSelf-citationWang, Z., Fan, J., Gao, K., Li, Z., Yi, Z., Wang, L., Huang, J., Yuan, C., Hong, W., Yu, S., et al. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-9956-0 · Cited by 47
“This process was completed by a trained research assistant through reviewing medical record(s) and using a scale described previously (Grof et al. 2002).”
MethodUpdate on bipolar disorder biomarker candidates
Teixeira, A. L., Salem, H., Frey, B. N., Barbosa, I. G., & Machado‐Vieira, R. (2016) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2016.1248413 · Cited by 50
Squassina, A., Manchia, M., Pisanu, C., Ardau, R., Arzedi, C., Bocchetta, A., Caria, P., Cocco, C., Congiu, D., Cossu, E., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-00844-z · Cited by 54
Higgins, G. A., Allyn-Feuer, A., Barbour, E., & Athey, B. D. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.106 · Cited by 47
Lithium: a key to the genetics of bipolar disorder
Cruceanu, C., Alda, M., & Turecki, G. (2009) · Genome Medicine · doi:10.1186/gm79 · Cited by 51
Self-citationPisanu, C., Papadima, E. M., Zompo, M. D., & Squassina, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.06.045 · Cited by 48
MiRNA-206 and BDNF genes interacted in bipolar I disorder.
Wang, Z., Zhang, C., Huang, J., Yuan, C., Hong, W., Chen, J., Yu, S., Xu, L., Gao, K., & Fang, Y. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.03.047 · Cited by 44
“This process was completed by a trained research assistant reviewing the appropriate medical records and using a scale described previously (Grof et al., 2002).”
Method
Metadata
- Authors
- Grof, P., Duffy, A., Cavazzoni, P., Grof, E., Garnham, J., MacDougall, M., O'Donovan, C., & Alda, M.
- Affiliations
- University of Ottawa (CA)
- Dalhousie University (CA)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-10-15
- Volume
- 63
- Issue
- 10
- Pages
- 942-947
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2136422355
- Semantic Scholar
- 5c8d39caedae6c6c21cb238faa737643cc7f8b07
- Cited by
- 438
- References
- 23
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 28 · 2023: 17 · 2022: 30 · 2021: 19 · 2020: 29 · 2019: 43 · 2018: 30 · 2017: 23 · 2016: 22 · 2015: 16 · 2014: 23 · 2013: 22 · 2012: 8
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- lithium response, bipolar disorder, family transmission, genetic susceptibility, long-term lithium therapy, treatment response
- MeSH terms
- Adult, Bipolar Disorder, Child, Dose-Response Relationship, Drug, Drug Administration Schedule, Family, Female, Humans, Lithium, Male, Middle Aged, Pharmacogenetics, Psychiatric Status Rating Scales, Retrospective Studies, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.